Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Insulet announces the commercial launch of Omnipod 5 AID system in Australia, with Dexcom G6 and G7 CGM sensor compatibility.

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

Nick Jonas writes about his diabetes journey, "The Last Five Years," fatherhood and more in this exclusive essay.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada ...

NSYNC entertainer diagnosed with rare form of diabetes that happens in adulthood but is more like Type 1 than Type 2.

The RDR acts as a sensor because of the varying dielectric permittivity linked to different glucose concentrations, leading to unique resonance frequencies and magnitude shifts. The bare sensor’s ...